Navigation Links
NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
Date:3/31/2011

atements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we believe that the assumptions on which the forward-looking statements contained herein are based are reasonable, any of those assumptions could prove to be inaccurate given the inherent uncertainties as to the occurrence or nonoccurrence of future events. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including the potential risks and uncertainties set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2010 and relate to our business plan, our business strategy, development of our proprietary technology platform and our products, timing of such development, timing and results of clinical trials, level and timing of FDA regulatory clearance or review, market acceptance of our products, protection of our intellectual property, implementation of our strategic, operating and people initiatives, benefits to be derived from personnel and directors, ability to commercialize our products, our assumptions regarding cash flow from operations and cash on-hand, the amount and timing of operating costs and capital expenditures relating to the expansion of our business, operations and infrastructure, implementation of marketing programs, our key agreements and strategic alliances, our ability to obtain additional capital as, and when, needed, and on acceptable terms and general economic conditions specific to our industry, any of which could impact sales, costs and expenses and/or planned strategies and timing. We assume no obligation to, and do not currently intend to, update these forward-looking statements.

To join
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. NewCardio Announces Positive Results From Third Clinical Validation Study
2. Vincent W. Renz Joins NewCardio as President
3. NewCardio Leadership to Present Two Abstracts at ISCE Conference
4. NewCardio Announces Master Services Agreement With Dedicated Phase I
5. NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit
6. NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress
7. NewCardio CEO Increases Equity Position
8. NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded Testing Dataset
9. NewCardio Announces Financial Results for Its 2010 Third Quarter
10. NewCardios Chief Technical Officer, Dr. Dorin Panescu, Named 2011 IEEE Fellow
11. NewCardio Presents Results for Cardiac Safety Research Consortium Blinded Drug Safety Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... PLYMOUTH MEETING, Pa. , Sept. 18, ... eClinical trial solutions, was recognized as the ... 2014 for its ePharmaONE cloud-based eClinical platform. ... portal and electronic trial master file (eTMF), ... informed-consent solution, and ePharmaSolutions, ReferralPlus+ patient screening ...
(Date:9/18/2014)... , Sept. 18, 2014   3D Systems   ... the Simbionix RobotiX Mentor™ , a new robotic surgery ... the first time at the ERUS exhibition in ... (booth #7). Robotic-assisted minimally invasive surgery represents a ... means the needs for training for robotic surgery has increased, ...
(Date:9/18/2014)... MELBOURNE, Australia , Sept. 18, 2014 ... appointments of Dr. Ashraf Hanna , M.D., Ph.D., ... its Board of Directors. Dr. Hanna is the Vice ... and Chief Financial Officer for the Genentech Foundation, while ... Global Head of Business Development and Licensing for Roche ...
Breaking Medicine Technology:ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 33D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3
... , CLEVELAND , Feb. ... and services company focused on global eClinical solutions for the ... Annual DIA Workshop in Japan for Clinical Data ... Coates , Vice President of Sales, will participate in the ...
... Feb. 2 PDI, Inc. (Nasdaq: PDII ), a leading ... announced that Chief Executive Officer Nancy Lurker will present at ... February 8-10, 2010 . , The presentation is scheduled for ... take place at The Grand Hyatt New York. , The webcast of ...
Cached Medicine Technology:DATATRAK Attends 13th Annual DIA Workshop in Japan for Clinical Data Management 2DATATRAK Attends 13th Annual DIA Workshop in Japan for Clinical Data Management 3
(Date:9/18/2014)... Alan Mozes HealthDay Reporter ... it comes to emergency room waiting times, patients seeking care ... staring down the clock than those seen at smaller or ... crowding and our ability to provide timely emergency care varies ... the authors of the new research, Dr. Renee Hsia, an ...
(Date:9/18/2014)... News) -- Daily supplements of selenium or vitamin E ... age-related cataracts among men, a new study indicates. ... could help prevent cataracts. To investigate this further, William ... School in Boston, and his colleagues examined data from ... The trial was initially designed to study prevention of ...
(Date:9/18/2014)... Physicians (CHEST) together with the Chinese Thoracic Society ... CTS that CHEST World Congress 2016 will be ... care, and sleep medicine from around the world ... for spring 2016. , CHEST World Congress ... simulation training, keynote addresses, presentations by leading health-care ...
(Date:9/18/2014)... TayganPoint Consulting Group, a leading strategic ... co-founder John Cassimatis was named as one of ... recognizing the region’s top healthcare and life science ... the year. , The Innovation Awards celebrate companies ... to shape the medical industry in Greater Philadelphia ...
(Date:9/18/2014)... 18, 2014 Qualis Health, one of ... a white paper, “Advancing Primary Care through the ... Technology.” , Authors Jeff Hummel, MD, MPH and ... to organizations engaged in the work of becoming a ... can bolster PCMH objectives, such as generating and providing ...
Breaking Medicine News(10 mins):Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2Health News:CHEST announces China as site of CHEST World Congress 2016 2Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Advancing Primary Care Through PCMH and HIT: New White Paper Connects the Dots 2
... , , LEAGUE CITY, Texas, ... has been dedicated to the insurance needs of seniors, with an ... insurance Agent. This has never been more evident than in the ... 3, 2009. , , With the advent of ...
... , , , , ... ), a leading provider of kidney care services for those diagnosed ... ranked 39th on the Environmental Protection Agency,s (EPA,s) FORTUNE 500 List ... as the only dialysis provider among the five healthcare companies featured ...
... , , , ATLANTA, Aug. 3 ... waffles with ketchup, kids are willing to eat anything when they get ... among parents, who want to ensure their kids bridge the gap between ... According to a national survey commissioned by frozen snack maker ...
... ... intensive designed specifically to help hospitals and health systems incorporate social media into marketing ... for Sept 16-17, 2009 in Chicago, IL. , ... Norfolk, Virginia (Vocus) - The Strategy Group announces a ...
... DALLAS Aug. 3, 2009 The new anti-wrinkle facial ... Botox, noticeably reduced frown lines between the eyes, according to ... at UT Southwestern Medical Center. "Our study confirmed that ... wrinkles," said Dr. Rod Rohrich, chairman of plastic surgery at ...
... , PT. RICHMOND, Calif., Aug. 2 Transcept Pharmaceuticals, Inc. ... its exclusive license and collaboration agreement with Purdue Pharmaceutical Products L.P. ... United States. The FDA has established October 30, 2009 as the ... ((R)) New Drug Application (NDA). , , ...
Cached Medicine News:Health News:SLAICO Takes the Medicare Supplement Application Online - Eliminating All Paperwork Offline. 2Health News:DaVita Only Dialysis Provider Named on EPA's FORTUNE 500 List of Green Power Purchasers 2Health News:DaVita Only Dialysis Provider Named on EPA's FORTUNE 500 List of Green Power Purchasers 3Health News:Parents Concerned About Kids' After-School Snacking Habits 2Health News:Innovator's Studio offers Social Media Strategy Intensive Sept 16-17, 2009 2Health News:Innovator's Studio offers Social Media Strategy Intensive Sept 16-17, 2009 3Health News:Dysport proves safe, effective anti-wrinkle treatment, UT Southwestern plastic surgeons find 2Health News:Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States 2
Fluoroperm 151 lens meets special needs of certain patients who need exceptional oxygen permeability for specific corneal condition or lifestyle requirements....
... Thinsite is designed using sophisticated lathing ... concepts. Thinsite lenses feature a center thickness ... ranges. While all plus powered Thinsite lenses ... over standard designs. The unique design eliminates ...
An easy-to-fit RGP daily wear lens with a unique bi-aspheric back surface design that provides excellent patient comfort and adaptation. Boston Envision contact lenses are an ideal alternative for vi...
Ophthalmic surgery stretcher. Designed for exceptional surgeon access, ideal for either superior or temporal approach....
Medicine Products: